TABLE 4.

Correlation of treatment outcome at 6 and 12 months of follow-up and PZA susceptibility^a

Treatment outcome	PZAs		PZAr
	No. (%) of participants	95% CI	No. (%) of participants	95% CI
Smear conversion
Yes (n = 121)	67 (98.5)	92.1–99.7	54 (96.4)	87.9–99.0
No (n = 3)	1 (1.5)	0.3–7.9	2 (3.6)	1.0–12.1
Culture conversion
Yes (n = 108)	60 (88.2)	78.5–93.9	48 (87.3)	76.0–93.7
No (n = 15)	8 (11.8)	6.1–21.5	7 (12.7)	6.3–24.0
Smear conversion at the following times (mo) after end of treatment:
1–2	37 (55.3)	43.4–66.5	26 (48.1)	35.4–61.1
3–4	22 (32.8)	22.8–44.7	21 (38.9)	27.04–52.2
5–6	7 (10.4)	5.2–20.0	5 (9.3)	4.0–19.9
7–12	1 (1.5)	0.3–8.0	2 (3.7)	1.0–12.5
Culture conversion at the following times (mo) after end of treatment:
1–2	33 (55)	42.5–66.9	23 (47.9)	34.5–61.7
3–4	23 (38.3)	27.1–51.0	20 (41.7)	28.8–55.7
5–6	3 (5.0)	1.7–13.7	3 (6.3)	2.1–16.8
7–12	1 (1.7)	0.3–8.8	2 (4.1)	1.1–14.0

^aData are for 124 participants.